Your session is about to expire
← Back to Search
Thrombectomy for Stroke (STAR Trial)
N/A
Recruiting
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
STAR Trial Summary
This international multi-center registry is used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an artery, abnormal tangling of blood vessels, abnormal formation of blood vessels, tearing of vein, and bleeding in the brain. This information is used to help predict outcomes that undergo an operation for treatment of the above-listed brain injuries. Additionally, the information is used to compare techniques and devices' effects on technical and clinical outcomes.
Eligible Conditions
- Stroke
- Brain Aneurysm
- Intracranial Thrombosis
STAR Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Complication rates
Occlusion rates
Post-procedure hemorrhage rate changes
+1 moreSTAR Trial Design
3Treatment groups
Experimental Treatment
Group I: ThrombectomyExperimental Treatment1 Intervention
Group II: StrokeExperimental Treatment1 Intervention
Group III: AneurysmExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Medical University of South CarolinaLead Sponsor
947 Previous Clinical Trials
7,358,068 Total Patients Enrolled
69 Trials studying Stroke
22,095 Patients Enrolled for Stroke
Meredith Robinson, MSStudy DirectorMedical University of South Carolina
Share this study with friends
Copy Link
Messenger